Not medical advice
Information on DoseVault is for educational purposes only and is not a substitute for medical advice, diagnosis, or treatment from a qualified healthcare provider.
You are viewing our development site. Please share feedback with support@dosevault.ai or on our Discord server. See what is new in the changelog.
Information on DoseVault is for educational purposes only and is not a substitute for medical advice, diagnosis, or treatment from a qualified healthcare provider.
We use strictly necessary cookies to keep you signed in. With your permission we'd also like to use anonymous analytics to improve the product. See our Cookie Policy and Privacy Policy.
111 compounds across peptides, hormones, and small molecules. 52 have full evidence profiles with mechanism summaries, evidence grades, and peer-reviewed citations. Information is for educational purposes only.
Sort
Compound class
Type
Evidence Grade
WADA Status
WADA status is educational and may change. Athletes are responsible for their own compliance with sport regulations; DoseVault accepts no liability. See the WADA reference for sources and dates.
Select filters to see what they mean.
Showing 111 of 111 compounds (52 with full profiles)
Small-molecule NNMT inhibitor that boosts NAD+ and white-fat mobilization.
Anti-aging tetrapeptide marketed for thymopoietic skin remodeling and firmness.
Adipotide is a ligand-directed peptidomimetic: a cyclic CKGGRAKDC motif binds prohibitin on the endothelial cells that line white-adipose-tissue blood vessels, and a fused proapoptotic D(KLAKLAK)2 sequence disrupts mitochondrial membranes once internalized.
Weekly GLP-1 agonist fused to albumin; discontinued GSK product (Tanzeum/Eperzan).
Oral ghrelin-receptor agonist developed for cancer cachexia; approved in Japan as Adlumiz.
Anastrozole is a potent, selective, reversible inhibitor of the aromatase enzyme (CYP19A1), which catalyzes the conversion of adrenal androgens (androstenedione and testosterone) to estrogens (estrone and estradiol) in peripheral tissues.
Modified HGH fragment 176-191 analog targeted at fat loss without GH side effects.
ARA-290 (cibinetide) is a short peptide modeled on the helix-B domain of erythropoietin.
Topical 'Botox alternative' acetyl hexapeptide for forehead and eye lines.
BPC-157 is a 15-amino-acid sequence derived from human gastric juice protein.
Russian actoprotectant adamantane; mild dopaminergic stimulant approved for asthenia.
Cagrilintide is a long-acting synthetic amylin analog that acts as an agonist at amylin receptors (AMY1, AMY2, AMY3) and the calcitonin receptor.
Semaglutide activates GLP-1 receptors to reduce appetite, slow gastric emptying, and improve glucose-dependent insulin secretion, while cagrilintide activates amylin receptors to promote satiety and slow gastric emptying.
Oral non-peptide ghrelin-receptor agonist; FDA-approved as a veterinary appetite stimulant.
Peptide mix for brain recovery.
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone (GHRH) with amino-acid substitutions that extend its plasma half-life.
Clomiphene interacts with estrogen receptors in the hypothalamus and pituitary, blocking estrogen-mediated negative feedback.
Khavinson tetrapeptide (Ala-Glu-Asp-Pro) marketed for cortical/CNS support.
Tyrosinase-inhibiting decapeptide used in melasma and hyperpigmentation serums.
DHEA is synthesized primarily in the adrenal cortex from cholesterol.
Dihexa was reported to bind hepatocyte growth factor (HGF) and potentiate signaling through its receptor c-Met, increasing spinogenesis and synaptogenesis in neuronal models.
DSIP (Delta Sleep-Inducing Peptide) is a nonapeptide originally isolated from rabbit brain during slow-wave sleep induction.
Common research-grade salt form of DSIP; same nine-aa sequence with TFA counterion.
Weekly GLP-1 receptor agonist fused to an IgG4 Fc fragment; sold as Trulicity by Eli Lilly.
Enclomiphene acts as an estrogen receptor antagonist primarily at hypothalamic and pituitary sites.
Epitalon (Ala-Glu-Asp-Gly) is a synthetic tetrapeptide developed as the chemically defined form of the pineal polypeptide extract Epithalamin.
Pineal-gland polypeptide extract; predecessor of Epitalon used in Russian gerontology.
Synonym/older spelling for Hexarelin; potent GH secretagogue with cardioprotective signaling.
First-in-class GLP-1 mimetic derived from Gila monster venom; sold as Byetta/Bydureon.
Cosmetic blend (hesperidin methyl chalcone + dipeptide-2 + pal-tetrapeptide-7) for under-eye bags.
Follistatin is an activin-binding glycoprotein that functions as a natural antagonist of myostatin and activin signaling via TGF-beta family pathways.
Senolytic D-retro-inverso peptide that disrupts FOXO4-p53 to selectively kill senescent cells.
TGF-beta family ligand controversially linked to age-reversal via parabiosis studies.
GHK-Cu (copper peptide) is a tripeptide (Gly-His-Lys) complexed with copper(II) that occurs naturally in human plasma, urine, and saliva.
Topical formulation of GHK-Cu for collagen, hair growth, and barrier repair without injection.
Native 44-aa hypothalamic GHRH; parent molecule of sermorelin, CJC-1295, and tesamorelin.
First-generation growth hormone-releasing hexapeptide; precursor to GHRP-2/-6.
GHRP-2 (pralmorelin) is a synthetic hexapeptide growth hormone secretagogue that activates the GHSR-1a receptor, stimulating GH release from the pituitary with greater potency than GHRP-6.
GHRP-6 is a synthetic hexapeptide GH secretagogue that potently stimulates the GHSR-1a receptor (ghrelin receptor), triggering pulsatile GH release.
Antioxidant Powerhouse.
Beta-endorphin C-terminal dipeptide investigated for opioid-tolerance modulation and CNS effects.
Gonadorelin binds the GnRH receptor on pituitary gonadotrophs, a Gq-coupled receptor that activates phospholipase C and downstream calcium and PKC signaling to drive synthesis and secretion of LH and FSH.
HCG shares its alpha subunit with LH, FSH, and TSH and carries a distinct beta subunit that binds the LH/hCG receptor with high affinity.
Hexarelin is a synthetic hexapeptide growth hormone secretagogue that acts as a potent GHSR agonist with additional binding at cardiac CD36 receptors.
Growth Hormone Essentials.
HGH Fragment 176-191 is a modified form of the C-terminal region of human growth hormone, comprising amino acids 176-191.
Inducible antimicrobial peptide active against Gram-negative bacteria and Candida.
Mitochondrial-derived peptide that protects against amyloid-beta and metabolic stress.
Truncated IGF-1 with localized hypertrophic action; favored for site-specific bodybuilding research.
Insulin-like Growth Factor 1 (IGF-1) is a 70-amino-acid single-chain peptide primarily secreted by the liver in response to GH stimulation.
Tryptophan-rich bovine cathelicidin; broad-spectrum antimicrobial peptide.
Ipamorelin is a synthetic pentapeptide that acts as a selective growth hormone secretagogue receptor (GHSR) agonist.
Pre-blended GH-stack vial; one injection, both peptides, popular 5+5 mg ratio.
Investigational blend pairing a clean GHRP (ipamorelin) with a stable GHRH (tesamorelin).
Hypothalamic peptide that triggers natural LH surge, a clean alternative to hCG/clomid stim.
Anti-aging hormone; soluble klotho boosts cognition and modulates phosphate/FGF23 axis.
KPV is a C-terminal tripeptide of alpha-MSH (Lys-Pro-Val) that retains anti-inflammatory activity via interaction with melanocortin receptors and nuclear NF-kB pathway inhibition, without the pigmentation-driving activity of the full alpha-MSH sequence.
Tight-junction regulator developed for celiac disease; reduces intestinal permeability.
Daily GLP-1 analog; FDA-approved for diabetes (Victoza) and obesity (Saxenda®).
Short-acting prandial GLP-1 agonist; sold as Adlyxin/Lyxumia by Sanofi.
LL-37 is the only known human cathelicidin antimicrobial peptide, derived from the C-terminus of the precursor protein hCAP18 by serine protease cleavage.
Shorter active fragments of LL-37 (KR-12, KS-30) with retained antimicrobial activity but lower toxicity.
Frog-skin-derived antimicrobial peptide; parent of the pexiganan topical antibiotic.
Pal-GHK + Pal-GQPR matrikines for collagen synthesis and skin firmness.
GLP-1 / glucagon dual agonist (Innovent / Eli Lilly) submitted in China for obesity 2024.
Melanotan I (afamelanotide) is a synthetic linear analogue of alpha-melanocyte stimulating hormone (alpha-MSH) that binds melanocortin-1 receptors (MC1R) in melanocytes, stimulating eumelanin synthesis.
Melanotan II is a cyclic heptapeptide analogue of alpha-MSH with non-selective melanocortin receptor activity spanning MC1R to MC5R.
IGF-1Ec splice variant released by mechanical loading; activates muscle satellite cells.
MK-677 (Ibutamoren) is an orally active small-molecule GH secretagogue that mimics ghrelin by binding GHSR-1a, stimulating pulsatile GH release and secondarily raising IGF-1.
MOTS-c is a mitochondria-derived peptide encoded by the 12S rRNA region of mitochondrial DNA.
Acetylated analog of Selank; anxiolytic with longer duration vs base Selank.
Acetylated, more stable analog of Semax; longer-acting nootropic via BDNF/NGF upregulation.
A potent nootropic for sharper thinking.
Hypothalamic neuropeptide regulating wakefulness; intranasal investigation for narcolepsy.
First oral non-peptide GLP-1 receptor agonist (Eli Lilly); Phase 3 obesity program.
Oxytocin is a nonapeptide produced in the hypothalamus and released by the posterior pituitary.
Peptide warrior against brain decline.
Lipidated GHK tripeptide; the second active in Matrixyl 3000 stack.
Original Matrixyl peptide; signals fibroblasts to upregulate collagen I/III and fibronectin.
Arginate-salt analog of BPC-157 developed for improved injection stability and tissue repair.
Khavinson tripeptide (Glu-Asp-Arg) marketed for pineal/CNS gerontoprotection.
Pregnenolone is synthesized from cholesterol by CYP11A1 (the mitochondrial side-chain cleavage enzyme) in steroidogenic tissues including adrenal glands, gonads, and brain.
PT-141 (bremelanotide) is a cyclic heptapeptide melanocortin receptor agonist derived from Melanotan II.
Retatrutide (LY3437943) is a long-acting triple agonist developed by Eli Lilly that simultaneously activates GLP-1, GIP, and glucagon receptors.
Combines retatrutide's triple agonism at GLP-1, GIP, and glucagon receptors with cagrilintide's long-acting amylin receptor agonism.
Hair Loss Fighter.
Selank is a synthetic heptapeptide derived from the immunomodulatory tetrapeptide Tuftsin with an additional stabilizing tripeptide tail.
Semaglutide is a GLP-1 receptor agonist approved for type 2 diabetes (Ozempic) and obesity management (Wegovy).
Semax is an ACTH(4-10) synthetic analogue developed in Russia that has been studied for neuroprotective and nootropic effects.
Sermorelin (GHRH 1-29 NH2) corresponds to the first 29 amino acids of endogenous growth hormone-releasing hormone and has been studied for its ability to stimulate pulsatile GH secretion from the anterior pituitary.
SLU-PP-332 is a synthetic agonist of the estrogen-related receptors (ERR-alpha, beta, gamma), orphan nuclear receptors that regulate mitochondrial biogenesis and oxidative metabolism in skeletal muscle.
Acetyl octapeptide-3; topical 'argireline-extended' for expression-line softening.
SS-31 (Elamipretide / MTP-131) is a cell-permeable aromatic-cationic tetrapeptide that selectively targets the inner mitochondrial membrane via electrostatic and hydrophobic interactions with cardiolipin.
Investigational GLP-1 / glucagon dual agonist from Boehringer Ingelheim and Zealand Pharma.
Tamoxifen and its active metabolites (4-hydroxytamoxifen and endoxifen) competitively bind estrogen receptors (ER-alpha and ER-beta).
TB-500 is a synthetic peptide fragment of Thymosin Beta-4, a 43-amino-acid protein ubiquitously expressed in mammalian cells.
Teduglutide is a recombinant analog of glucagon-like peptide-2 (GLP-2) with a Gly2 substitution that resists DPP-4 degradation, extending its activity relative to native GLP-2.
Tesamorelin is an FDA-approved synthetic analogue of GHRH indicated for HIV-associated lipodystrophy.
Triple monoamine reuptake inhibitor with strong weight-loss data; not FDA-approved.
Tesofensine paired with metoprolol (Tesomet) to control HR while preserving weight loss.
After intramuscular or subcutaneous injection, testosterone cypionate is hydrolyzed by esterases to free testosterone.
Testosterone enanthate is hydrolyzed after injection to free testosterone, which binds the intracellular androgen receptor.
Testosterone propionate is rapidly hydrolyzed after intramuscular injection to free testosterone.
Testosterone undecanoate is a long-chain ester hydrolyzed to free testosterone after deep intramuscular injection into the gluteal muscle, providing sustained release over weeks.
Thymus polypeptide extract used in Russian/CIS clinics for immune support; sister product to Thymosin.
Thymosin Alpha-1 (Talpha1) is a 28-amino-acid acetylated peptide originally isolated from thymic tissue.
Thymulin is a thymic nonapeptide (FTS) that becomes biologically active only when bound to zinc in a 1:1 ratio, forming the conformational epitope its targets recognize.
Tirzepatide is a dual GIP/GLP-1 receptor agonist approved by the FDA for type 2 diabetes (Mounjaro) and obesity (Zepbound).
Free GHK tripeptide (Gly-His-Lys), the parent motif of GHK-Cu skincare actives.
Khavinson tripeptide (Lys-Glu-Asp) marketed as a vascular bioregulator.
VIP is a 28-amino-acid member of the secretin/glucagon peptide family that signals through the VPAC1 and VPAC2 G-protein-coupled receptors.